Merck KGaA (OTCMKTS:MKKGY) Reaches New 52-Week Low – Should You Sell?

Shares of Merck KGaA (OTCMKTS:MKKGY) hit a new 52-week low on Thursday . The company traded as low as $28.96 and last traded at $29.08, with a volume of 139382 shares trading hands. The stock had previously closed at $29.31.

Analyst Ratings Changes

Separately, The Goldman Sachs Group initiated coverage on Merck KGaA in a report on Thursday, September 19th. They set a “buy” rating on the stock.

Merck KGaA Trading Up 1.5 %

The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The firm has a market cap of $19.08 billion, a PE ratio of 18.23, a price-to-earnings-growth ratio of 2.25 and a beta of 0.96. The company’s 50 day moving average price is $33.63 and its 200 day moving average price is $34.99.

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.